文章摘要
咽神经肌肉电刺激仪对老年脑卒中不同分期吞咽功能障碍患者的疗效
To evaluate the efficacy of pharyngeal neuromuscular electrical stimulation in elderly stroke patients with dysphagia at different stages
投稿时间:2024-07-25  修订日期:2024-07-25
DOI:
中文关键词: 咽神经肌肉电刺激仪  老年脑卒中  不同分期  吞咽功能障碍  疗效
英文关键词: pharyngeal neuromuscular electrical stimulator  stroke in the elderly  different stages  swallowing dysfunction  efficacy
基金项目:
作者单位邮编
关清秀 首都医科大学附属北京地坛医院顺义院区 101300
摘要点击次数: 9
全文下载次数: 0
中文摘要:
      目的:探讨咽神经肌肉电刺激仪对老年脑卒中不同分期吞咽功能障碍患者的疗效。方法:选择2019年1月~2023年1月于我院就诊的老年脑卒中吞咽功能障碍患者120例随机分为两组,对照组予以常规吞咽功能训练,研究组在此基础上增加咽神经肌肉电刺激。比较2组不同分期治疗前后营养状态、神经营养因子、免疫功能、超声检查相关参数、表面肌电图(sEMG)、吞咽功能相关评分以及临床疗效。广义估计方程(GEE)分析临床疗效的影响因素以及时点、组别和分期的交互效应。结果:研究组治疗4周后白蛋白(ALB)、血红蛋白(Hb)、脑源性神经营养因子(BDNF)、神经生长因子(NGF)、胰岛素样生长因子(IGF)-1、CD3+、CD4+、CD4+/CD8+、舌厚度、运动幅度、运动速度、最大距离、缩短距离、缩短率、最大波幅值、改良Barthel指数以及藤岛一郎吞咽疗效评分均显著高于对照组,CD8+、运动时间、最小距离、吞咽时间、标准吞咽功能评价量表(SSA)评分均显著低于对照组。GEE模型分析结果显示治疗时间及分期显著影响治疗效果。交互效应分析中治疗2周时,2组中咽期吞咽障碍患者临床疗效差异显著,而治疗4周时,2组中咽期和口咽混合期吞咽障碍患者临床疗效差异显著。结论:咽神经电刺激仪治疗老年脑卒中不同分期吞咽功能障碍在营养状态、神经营养因子、免疫功能、超声检查相关参数、sEMG、吞咽功能相关评分等指标的改善方面优于常规吞咽功能训练,且在咽期效果最优。
英文摘要:
      Objective: To investigate the effect of pharyngeal neuromuscular electrical stimulation on dysphagia in elderly stroke patients at different stages. Methods: A total of 120 elderly stroke patients with swallowing dysfunction treated in our hospital from January 2019 to January 2023 were randomly divided into two groups. The control group was given routine swallowing function training, and the study group was added pharyngeal neuromuscular electrical stimulation on the basis of the control group. The nutritional status, neurotrophic factors, immune function, ultrasound parameters, surface electromyography (sEMG), swallowing function scores and clinical efficacy of the two groups were compared before and after treatment at different stages. Generalized estimation equation (GEE) model was used to analyze the influencing factors of clinical efficacy and the interaction effects of time point, group and stage. Results: After 4 weeks of treatment, albumin (ALB), hemoglobin (Hb), brain-derived neurotrophic factor (BDNF), nerve growth factor (nerve growth factor) NGF), insulin growth factor (insulin growth factor, IGF) -1, CD3+, CD4+, CD4+/CD8+, tongue thickness, motion range, motion velocity, maximum distance, shortening distance, shortening rate, maximum amplitude, modified Barthel index and Fujijima's swallowing efficacy score were significantly higher than those of the control group. CD8+, exercise time, minimum distance, swallowing time, standardized swallowing assessment (SSA) score were significantly lower than control group, CD4+/CD8+, maximum amplitude and modified GEE model analysis showed that treatment time and different stages significantly affected the therapeutic effect. In the interaction effect analysis, there was a significant difference in clinical efficacy between the two groups at 2 weeks of treatment, while there was a significant difference between the two groups at 4 weeks of treatment between the two groups at the middle pharyngeal stage and the mixed oropharyngeal stage. Conclusion: In the treatment of swallowing dysfunction in different stages of senile stroke, pharyngeal nerve electrostimulator is superior to conventional swallowing function training in terms of nutritional status, neurotrophic factors, immune function, parameters related to ultrasound examination, sEMG, and scores related to swallowing function, and the effect is optimal in pharyngeal stage.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭